$3250 | Single User
$4650 | Site License
$5650 | Global License

Gastrointestinal Disease Treatment Market, By Types (Branded, Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others and Generics), By Route (Oral, IV, Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270589 | In Stock
Related Topics: Abbott , Cancer , COVID , Gas , Gastroenterology , GlaxoSmithKline , Humira , Nexium , Pfizer , Pharmaceuticals

Introduction

REPORT HIGHLIGHT

The gastrointestinal disease treatment market is estimated to represent a global market of USD 42.6 billion by 2019 with growth rate of 5.8%.

Market Dynamics

Gastrointestinal disorders are functional disorders that affect the sections of GIT track and its accessory organs such as the pancreas, salivary glands, and liver. This disorder includes chronic, acute, recurrent as well as functional disorders which cover wide range of GIT track diseases. Some of the most common GIT disorders include Crohn’s disease, GIT cancers, inflammatory bowel disease, irritable bowel syndrome, diarrhea, dyspepsia, and others. The continuous increase in the prevalence of these diseases is expected to support the market growth to great extent.

As per the World Health Organizations, colon cancer caused more than 694 000 deaths in 2014. A report published by the American Cancer Society also stated that around 100,000 colon cancer cases were diagnosed in the U.S. alone, which is expected to increase by 62% till 2030. Such high prevalence rate will upsurge the demand for GIT therapeutics, leading to driving the market growth. Additionally, the emergence of novel therapeutics such as biosimilar is considered to be the most important driver for this market. Biosimilar contains identical active pharmaceutical ingredients which offer effective treatment for the GIT disorders such as inflammatory disorders and others. Rise in the usage of biologics for the treatment of GIT disorders is also anticipated to encourage the market growth.

Furthermore, according to the various research studies, the social and economic burden of GIT disorders are enormous. For instance, in December 2015, the article published by an online publication “Gastroenterology” stated that gastrointestinal disease is the source of substantial burden in terms of mortality, morbidity, and cost to the U.S. population. Therefore, various organizations such as the World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) are actively devoted to encouraging scientists to develop novel therapeutics to cure this disease, providing the healthy platform for the market growth.

However, patient expiry for some of the blockbuster therapeutics hampers the market growth to some extent. Humira that accounted for more than 55% share of biologics used for the treatment of gastrointestinal diseases, expired in 2016. This has caused a steep decline in the revenue generated by gastrointestinal therapeutics.

Types Takeaway

The market is majorly categorized as Branded and Generics. The branded segment accounted for the largest share of the total market, captured more than 72.56% share in 2019. Branded segment is further categorized as Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others. Of these, proton pump inhibitors recorded the highest revenue i.e. USD 4.8 billion in 2019.

However, the segment is projected to grow with the negative growth rate over the forecast period owing to the loss of patent and exclusivity of major drugs, such as Nexium and Prilosec. Among the different drug class, biologics are anticipated to grow with the highest growth rate, i.e. 11.6% over the forecast period. In 2021-2027, this segment is projected to lead the market with more than USD 17.4 billion revenue generation.

COVID-19 Impact & Recovery Analysis

The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.

Regional Takeaway

Geographically, North America dominated the global market. In 2019, the region recorded USD 14.48 billion and is projected to dominate the market in future. Favorable government initiatives to increase the uptake of gastrointestinal therapeutics drive the market growth in this region. For instance, the Integrated Global Action Plan for Diarrhoea by UNICEF and WHO aims at minimizing preventable childhood deaths due to diarrhea by providing interventions and services to raise awareness and provide access to treatment and preventive measures. However, Asia Pacific region is expected to grow with the highest CAGR over the forecast period.

Key Vendor Takeaway

The report also discusses the leading players in global gastrointestinal therapeutics market. The report enlists companies such as Abbott, Allergan, GlaxoSmithKline plc, Takeda Pharmaceutical and Pfizer, Inc., among others. Strategic collaboration and new product proliferation have made this market very dynamic. The collaboration of multinational companies with small-scale participants creates rivalry among key players.

For example, in September 2019, Takeda Pharmaceuticals collaborated with Structural Genomics Consortium (SGC) to develop new intervention methods for the treatment of inflammatory bowel disease. This implies that strategic engagement to expand product offering is considered to be one of the most factors.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

Table of Contents
for Gastrointestinal Disease Treatment Market, By Types (Branded, Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others and Generics), By Route (Oral, IV, Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

  • TABLE OF CONTENT

    1. GASTROINTESTINAL DISEASE TREATMENT MARKET OVERVIEW

    1.1. Study Scope

    1.2. Base Year

    1.3. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. GASTROINTESTINAL DISEASE TREATMENT KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. GASTROINTESTINAL DISEASE TREATMENT INDUSTRY STUDY

    4.1. Company Activity Analysis

    4.2. Regulatory Framework Analysis

    4.3. Market Attractiveness Analysis

    4.4. Value Chain Analysis

    5. GASTROINTESTINAL DISEASE TREATMENT MARKET LANDSCAPE

    5.1. Market Share Analysis

    5.2. Key Innovators

    6. GASTROINTESTINAL DISEASE TREATMENT MARKET – BY DRUG CATEGORY:

    6.1. Overview

    6.2. Branded

    6.2.1.1. Overview

    6.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.2. Proton Pump Inhibitors

    6.2.2.1. Overview

    6.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.3. Enzyme Replacement Therapies

    6.2.3.1. Overview

    6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.4. Amino-salicylates

    6.2.4.1. Overview

    6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.5. Antacids

    6.2.5.1. Overview

    6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.6. Anti-emetics

    6.2.6.1. Overview

    6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.7. Anti-diarrheal

    6.2.7.1. Overview

    6.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.8. Biologics

    6.2.8.1. Overview

    6.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.2.9. Others

    6.2.9.1. Overview

    6.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.3. Generics

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7. GASTROINTESTINAL DISEASE TREATMENT MARKET – BY ROUE OF ADMINISTRATION:

    7.1. Overview

    7.2. Oral

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.3. IV

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.4. Others

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8. GASTROINTESTINAL DISEASE TREATMENT MARKET– BY GEOGRAPHY

    8.1. Introduction

    8.2. North America

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.3. U.S.

    8.2.3.1. Overview

    8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.4. Canada

    8.2.4.1. Overview

    8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3. Europe

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.3. France

    8.3.3.1. Overview

    8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.4. Germany

    8.3.4.1. Overview

    8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.5. Rest of Europe

    8.3.5.1. Overview

    8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4. Asia Pacific (APAC)

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.3. China

    8.4.3.1. Overview

    8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.4. India

    8.4.4.1. Overview

    8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.5. Rest of APAC

    8.4.5.1. Overview

    8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5. Rest of the World

    8.5.1. Overview

    8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.3. Latin America

    8.5.3.1. Overview

    8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.4. Middle East and Africa

    8.5.4.1. Overview

    8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9. KEY VENDOR ANALYSIS

    9.1. Abbott

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.2. Allergan

    9.2.1. Company Overview

    9.2.2. SWOT Analysis

    9.2.3. Key Developments

    9.3. GlaxoSmithKline plc

    9.3.1. Company Overview

    9.3.2. SWOT Analysis

    9.3.3. Key Developments

    9.4. Phillips Healthcare

    9.4.1. Company Overview

    9.4.2. SWOT Analysis

    9.4.3. Key Developments

    9.5. Takeda Pharmaceutical

    9.5.1. Company Overview

    9.5.2. SWOT Analysis

    9.5.3. Key Developments

    9.6. Pfizer, Inc.

    9.6.1. Company Overview

    9.6.2. SWOT Analysis

    9.6.3. Key Developments

    *Client can request additional company profiling as per specific requirements

    10. 360 DEGREE ANALYSTVIEW

    11. APPENDIX

    11.1. Research Methodology

    11.2. Abbreviations

    11.3. Disclaimer

    11.4. Contact Us

List Of Tables
in Gastrointestinal Disease Treatment Market, By Types (Branded, Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others and Generics), By Route (Oral, IV, Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global Gastrointestinal Disease Treatment Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Table 10 Gastrointestinal Disease Treatment Market, by Drug Cateory, 2016 – 2027 (USD Million)

Table 11 Gastrointestinal Disease Treatment Market, by Route of Administration, 2016 – 2027 (USD Million)

Table 12 Gastrointestinal Disease Treatment Market, by Geography, 2016 – 2027 (USD Million)

Table 13 North America Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 14 U.S. Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 15 Canada Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 16 Europe Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 17 France Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 18 Germany Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 19 Asia Pacific Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 20 China Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 21 India Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 22 Latin America Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

Table 23 MEA Gastrointestinal Disease Treatment Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Gastrointestinal Disease Treatment Market, By Types (Branded, Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others and Generics), By Route (Oral, IV, Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated

List of Figures

Figure 1 Research Methodology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 Gastrointestinal Disease Treatment Market, by Drug Category, 2016 – 2027 (USD Million)

Figure 7 Gastrointestinal Disease Treatment Market, by Route of Administration, 2016 – 2027 (USD Million)

Figure 8 Gastrointestinal Disease Treatment Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270589 | AV144

Number of Pages

216

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016
Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016Summa...
30 Nov 2016 by Global Data USD $2,500 More Info
Global Gastrointestinal Partnering 2010-2016: Deal trends, players and financials
Global Gastrointestinal Partnering 2010 to 2016 provides the full collection of Gastrointestinal dis...
01 Nov 2016 by Current Partnering USD $2,995 More Info
Global Gastrointestinal Symptoms Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Gastrointestinal Partnering 2010-2016: Deal trends, players and financials
Global Gastrointestinal Partnering 2010 to 2016 provides the full collection of Gastrointestinal dis...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Global Gastrointestinal Symptoms Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies,...
13 Sep 2016 by GBI Research USD $4,995 More Info
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies,...
13 Sep 2016 by GBI Research USD $4,995 More Info
North America Endoscopic Accessories Market - By Product (Carts, Cleaning Adapters, Lubrication Gel), By Application (Laparoscopy, Gastrointestinal Endoscopy), By Country (U.S. Canada Mexico) FORECASTS TO 2021
The North America endoscopic accessories market has been segmented based on product, application, an...
01 Aug 2016 by MicroMarketMonitor USD $2,650 More Info
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016SummaryGlobalData's cli...
31 May 2016 by Global Data USD $2,500 More Info
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016
Gastrointestinal Stromal Tumor (GIST) Global Clinical Trials Review, H1, 2016SummaryGlobalData's cli...
31 May 2016 by Global Data USD $2,500 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Gastrointestinal Disease Treatment Market, By Types (Branded, Proton Pump Inhibitors, Enzyme Replacement Therapies, Amino-salicylates, Antacids, Anti-emetics, Anti-diarrheal, Biologics, and Others and Generics), By Route (Oral, IV, Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2016 – 2027- COVID- 19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...